1小时血浆葡萄糖诊断2型糖尿病优于空腹血糖、2小时血糖与HbA1c
研究基于KoGES、CATAMERI、GENFIEV、PLIS随访和TULIP随访五个独立队列,比较1小时血浆葡萄糖(1 h PG)与空腹血糖(FPG)、2小时血浆葡萄糖(2 h PG)、HbA1c及HbA1c联合FPG诊断2型糖尿病的效能。各队列中1 h PG的AUC均高于FPG联合HbA1c(均p<0.001);五队列荟萃分析(N=11,968)显示1 h PG合并AUC为0.97(95%CI 0.96, 0.98),优于FPG联合HbA1c的0.85(95%CI 0.82, 0.88)。结论支持IDF推荐的1 h PG在诊断2型糖尿病上优于上述其他指标。
要点
- 1 h PG诊断2型糖尿病的判别效能优于FPG、2 h PG、HbA1c及HbA1c联合FPG。
- 五队列荟萃分析合并AUC:1 h PG为0.97,FPG联合HbA1c为0.85。
- IDF采用的1 h PG诊断阈值为≥11.6 mmol/l(≥209 mg/dl)。
核心结论
- 研究结果支持IDF推荐的1 h PG在诊断2型糖尿病方面优于FPG、2 h PG、HbA1c以及FPG联合HbA1c。
研究设计与样本
- 基于五个独立队列数据的分析:KoGES、CATAMERI、GENFIEV、PLIS(随访)和TULIP(随访)。
- 采用ROC曲线下面积(AUC-ROC)评估1 h PG相对于FPG和HbA1c单独及联合诊断糖尿病的能力。
- 采用随机效应荟萃分析汇总各研究数据,合并五队列共N=11,968。
主要发现
- KoGES队列1 h PG的AUC为0.96 vs 0.88(Δ 0.08),灵敏度84.2 vs 77.0,特异度98.6 vs 87.0。
- CATAMERI队列AUC 0.98 vs 0.86(Δ 0.12),GENFIEV队列AUC 0.97 vs 0.89(Δ 0.08),均与FPG联合HbA1c比较,所有p<0.001。
- PLIS随访AUC 0.98 vs 0.76(Δ 0.22),TULIP随访AUC 0.98 vs 0.83(Δ 0.15),均与FPG联合HbA1c比较,所有p<0.001。
- 荟萃分析合并AUC(95%CI):1 h PG为0.97(0.96, 0.98),FPG联合HbA1c为0.85(0.82, 0.88)。
关键数值与推荐
- 2型糖尿病按ADA标准定义:FPG ≥7.0 mmol/l(≥126 mg/dl)、2 h PG ≥11.1 mmol/l(≥200 mg/dl)或HbA1c ≥48 mmol/mol(≥6.5%)。
- 按IDF标准定义:1 h PG ≥11.6 mmol/l(≥209 mg/dl)。
临床怎么用
- 在诊断2型糖尿病时,可考虑采用IDF推荐的1 h PG作为口服葡萄糖耐量试验中的补充或替代判别指标。
- 1 h PG判别的灵敏度和特异度在多个队列中均高于FPG联合HbA1c,有助于减少漏诊和误诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The IDF has proposed 1 h plasma glucose (1 h PG) as a diagnostic test for type 2 diabetes. This study evaluated the utility of 1 h PG in diagnosing type 2 diabetes, compared with fasting plasma glucose (FPG), 2 h plasma glucose (2 h PG), HbA1c and the combination of HbA1c plus FPG. METHODS: Analyses were conducted using data from five independent cohorts: KoGES, CATAMERI, GENFIEV, PLIS (follow-up) and TULIP (follow-up). Type 2 diabetes was defined according to ADA criteria (FPG ≥7.0 mmol/l [≥126 mg/dl], 2 h PG ≥11.1 mmol/l [≥200 mg/dl] or HbA1c ≥48 mmol/mol [≥6.5%]) or IDF criteria (1 h PG ≥11.6 mmol/l [≥209 mg/dl]). Area under of the receiver operating characteristic curves (AUC-ROCs) were used to assess the performance of 1 h PG relative to FPG and HbA1c, individually and in combination, for diagnosing diabetes. Random-effects meta-analyses were applied to pooled data to summarise the overall diagnostic accuracy across studies. RESULTS: Cohort-specific analyses demonstrated consistently higher AUCs for 1 h PG in KoGES (AUC 0.96 vs 0.88; Δ 0.08; sensitivity 84.2 vs 77.0; specificity 98.6 vs 87.0), CATAMERI (AUC 0.98 vs 0.86; Δ 0.12; sensitivity 75.0 vs 69.4; specificity: 98.4 vs 78.9), GENFIEV (AUC 0.97 vs 0.89; Δ 0.08; sensitivity 89.5 vs 69.4; specificity 100.0 vs 88.3), PLIS follow-up (AUC 0.98 vs 0.76; Δ 0.22; sensitivity 94.9 vs 46.8; specificity 100.0 vs 92.3) and TULIP follow-up (AUC 0.98 vs 0.83; Δ 0.15; sensitivity 90.2 vs 90.2; specificity 100.0 vs 65.0) compared with FPG plus HbA1c (all p<0.001). Meta-analysis of five cohorts (N=11,968) revealed superior diagnostic performance of 1 h PG compared with FPG plus HbA1c, with pooled AUCs (95% CI) of 0.97 (0.96, 0.98) vs 0.85 (0.82, 0.88). CONCLUSIONS/INTERPRETATION: These findings support the superior utility of the IDF-recommended 1 h PG vs FPG, 2 h PG, HbA1c and FPG plus HbA1c for diagnosing type 2 diabetes.
引用
- Wang Y, Ram J, Bianchi C, et al. Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA1c for the diagnosis of type 2 diabetes. Diabetologia. 2025. PMID: 41388091. doi:10.1007/s00125-025-06632-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。